Structures by: Kovalenko S. M.
Total: 37
C10H8N2OS
C10H8N2OS
CrystEngComm (2019)
a=7.3622(12)Å b=7.8278(13)Å c=9.5248(18)Å
α=73.758(15)° β=69.604(16)° γ=68.658(15)°
C10H8N2O2
C10H8N2O2
CrystEngComm (2019)
a=4.7260(9)Å b=14.633(3)Å c=12.5056(17)Å
α=90° β=93.970(14)° γ=90°
C10H7NO2S
C10H7NO2S
CrystEngComm (2019)
a=11.3493(10)Å b=5.6476(4)Å c=14.2419(10)Å
α=90° β=100.689(8)° γ=90°
Methyl 4-amino-3-phenylisothiazole-5-carboxylate
C11H10N2O2S
Acta Crystallographica Section C (2021) 77, 1
a=3.9876(5)Å b=10.6511(13)Å c=25.107(2)Å
α=90° β=90° γ=90°
Methyl 4-amino-3-phenylisothiazole-5-carboxylate
C11H10N2O2S
Acta Crystallographica Section C (2021) 77, 1
a=6.9210(9)Å b=7.2371(17)Å c=42.396(8)Å
α=90° β=90° γ=90°
3-Cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1,2,4-oxadiazole
C12H11N5O
Acta Crystallographica Section C (2021) 77, 1
a=4.4041(4)Å b=27.8787(18)Å c=9.3533(8)Å
α=90° β=100.816(7)° γ=90°
3-Cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1,2,4-oxadiazole
C12H11N5O
Acta Crystallographica Section C (2021) 77, 1
a=12.2191(13)Å b=8.1593(9)Å c=22.788(2)Å
α=90° β=90° γ=90°
3-Cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
C10H11N5O
Acta Crystallographica Section C (2020) 76, 8
a=8.4476(10)Å b=8.5662(8)Å c=8.6125(8)Å
α=110.812(9)° β=115.048(11)° γ=92.854(9)°
3-Cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
C10H11N5O
Acta Crystallographica Section C (2020) 76, 8
a=4.8240(11)Å b=8.2685(19)Å c=26.527(10)Å
α=90° β=90° γ=90°
3-(5-Phenyl-1,3,4-oxadiazol-2-yl)-2<i>H</i>-chromen-2-one
C17H10N2O3
Acta Crystallographica Section C (2019) 75, 11
a=15.611(5)Å b=3.8414(9)Å c=21.974(7)Å
α=90° β=90.74(3)° γ=90°
3-(5-Phenyl-1,3,4-oxadiazol-2-yl)-2<i>H</i>-chromen-2-one
C17H10N2O3
Acta Crystallographica Section C (2019) 75, 11
a=13.9075(11)Å b=5.1543(5)Å c=18.8010(16)Å
α=90° β=97.772(8)° γ=90°
3-(5-Phenyl-1,3,4-oxadiazol-2-yl)-2<i>H</i>-chromen-2-one
C17H10N2O3
Acta Crystallographica Section C (2019) 75, 11
a=3.9158(8)Å b=17.717(3)Å c=18.832(3)Å
α=90° β=94.670(16)° γ=90°
3-[5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-2<i>H</i>-chromen-2-one
C16H9N3O3
Acta Crystallographica Section C (2019) 75, 11
a=20.931(2)Å b=3.7708(5)Å c=16.0887(15)Å
α=90° β=90° γ=90°
3-[5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-2<i>H</i>-chromen-2-one
C16H9N3O3
Acta Crystallographica Section C (2019) 75, 11
a=3.7788(9)Å b=9.9655(17)Å c=16.899(3)Å
α=90° β=93.466(19)° γ=90°
3-(3-Phenyl-1<i>H</i>-1,2,4-triazol-5-yl)-2<i>H</i>-1-benzopyran-2-one
C17H11N3O2
Acta Crystallographica Section C (2019) 75, 6 822-832
a=6.8415(7)Å b=10.8931(12)Å c=20.163(2)Å
α=74.965(9)° β=83.815(9)° γ=72.183(10)°
3-(3-Phenyl-1<i>H</i>-1,2,4-triazol-5-yl)-2<i>H</i>-1-benzopyran-2-one
C17H11N3O2
Acta Crystallographica Section C (2019) 75, 6 822-832
a=6.8355(11)Å b=19.512(3)Å c=10.881(2)Å
α=90° β=107.811(19)° γ=90°
3-(3-Phenyl-1<i>H</i>-1,2,4-triazol-5-yl)-2<i>H</i>-1-benzopyran-2-one
C17H11N3O2
Acta Crystallographica Section C (2019) 75, 6 822-832
a=13.0369(8)Å b=13.0804(7)Å c=16.2223(8)Å
α=90° β=90° γ=90°
C17H14N2O2
C17H14N2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.8956(7)Å b=9.6425(15)Å c=14.958(2)Å
α=103.662(13)° β=94.580(12)° γ=98.382(12)°
C16H12N2O2
C16H12N2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.8281(10)Å b=8.5805(13)Å c=15.436(2)Å
α=96.790(13)° β=95.002(15)° γ=91.404(15)°
C16H11FN2O2
C16H11FN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.6371(13)Å b=8.957(3)Å c=15.788(6)Å
α=99.88(3)° β=96.61(3)° γ=93.21(3)°
C16H11FN2O2
C16H11FN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.6995(14)Å b=30.579(8)Å c=8.853(3)Å
α=90° β=92.70(2)° γ=90°
C16H11ClN2O2
C16H11ClN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.3746(9)Å b=30.823(5)Å c=9.855(3)Å
α=90° β=93.225(17)° γ=90°
C16H11BrN2O2
C16H11BrN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.1661(2)Å b=31.0277(16)Å c=10.4434(6)Å
α=90° β=92.933(4)° γ=90°
C16H11BrN2O2
C16H11BrN2O2
Acta Crystallographica Section B (2019) 75, 5
a=6.9397(5)Å b=10.2611(8)Å c=20.7644(12)Å
α=90° β=96.919(7)° γ=90°
C16H11IN2O2
C16H11IN2O2
Acta Crystallographica Section B (2019) 75, 5
a=6.9395(2)Å b=10.2583(4)Å c=20.7605(6)Å
α=90° β=96.931(3)° γ=90°
C17H14N2O3
C17H14N2O3
Acta Crystallographica Section B (2019) 75, 5
a=6.9921(13)Å b=10.1424(15)Å c=20.862(3)Å
α=90° β=99.570(16)° γ=90°
Ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2<i>H</i>-1,2,6-thiadiazine-4-carboxylate
C15H22N4O5S
Acta Crystallographica Section E (2020) 76, 1 12-17
a=12.4962(5)Å b=9.9237(4)Å c=29.5925(15)Å
α=90° β=90° γ=90°
C25H18Cl3N3O4
C25H18Cl3N3O4
Acta Crystallographica Section E (2004) 60, 2 o187-o189
a=9.020(2)Å b=11.390(3)Å c=12.890(3)Å
α=73.95(2)° β=86.18(2)° γ=67.49(2)°
C25H22N3O21,Cl1,C2H4O2
C25H22N3O21,Cl1,C2H4O2
Acta Crystallographica Section E (2004) 60, 2 o294-o296
a=21.224(7)Å b=15.830(4)Å c=15.550(5)Å
α=90° β=109.42(3)° γ=90°
C23H23N3O3,H2O
C23H23N3O3,H2O
Acta Crystallographica Section E (2004) 60, 8 o1417-o1418
a=9.465(2)Å b=10.316(2)Å c=12.518(3)Å
α=79.521(17)° β=88.450(17)° γ=64.259(17)°
[3-Amino-5-(3,5-dimethylanilino)-4-phenylsulfonyl-2-thienyl]phenylmethanone
C25H22N2O3S2
Acta Crystallographica Section E (2007) 63, 6 o3011-o3011
a=10.497(3)Å b=11.451(3)Å c=11.863(3)Å
α=65.65(2)° β=69.654(19)° γ=70.18(2)°
Ethyl 6-ethoxy-10-(3-methoxypropyl)-9-methyl-11-thioxo-8-oxa-10,12- diazatricyclo[7.3.1.0^2,7^]trideca-2,4,6-triene-13-carboxylate
C20H28N2O5S
Acta Crystallographica Section E (2007) 63, 12 o4906-o4906
a=9.7612(16)Å b=10.3405(17)Å c=12.309(2)Å
α=107.354(13)° β=109.709(13)° γ=100.096(12)°
2,3,4,6,7,8,9,10-Octahydropyrimido[1,2-<i>a</i>]azepin-1-ium 2-cyano-1-(2,6-dimethylanilino)-2-(phenylsulfonyl)ethenethiolate
C9H17N2,C17H15N2O2S2
Acta Crystallographica Section E (2008) 64, 1 o255-o255
a=8.3278(5)Å b=11.348(4)Å c=13.661(3)Å
α=104.03(2)° β=92.517(9)° γ=90.635(12)°
5-[(3,4-Dimethylphenyl)sulfonyl]-8-methoxy-2-methyl-2,3,5,6-tetrahydro-4H- 2,6-methano-1,3-benzoxazocin-4-one
C21H23NO5S
Acta Crystallographica Section E (2007) 63, 12 o4845-o4845
a=8.077(4)Å b=11.153(6)Å c=11.724(6)Å
α=94.77(4)° β=106.22(4)° γ=98.36(4)°
1-(8-Bromo-2-methyl-4-thioxo-3,4,5,6-tetrahydro-2<i>H</i>-2,6-methano-1,3- benzoxazocin-11-yl)ethanone
C14H14BrNO2S
Acta Crystallographica Section E (2009) 65, 3 o461
a=8.213(5)Å b=11.625(7)Å c=15.156(10)Å
α=98.67(5)° β=99.09(5)° γ=101.81(5)°
Sodium 2-[1-methyl-5-(4-methylbenzoyl)-1<i>H</i>-pyrrol-2-yl]acetate dihydrate
2(Na),2(C15H14N1O3),4(H2O1)
Acta Crystallographica Section E (2021) 77, 2 134-137
a=8.5404(8)Å b=9.0144(9)Å c=21.6217(19)Å
α=92.922(8)° β=98.873(7)° γ=113.038(9)°